Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
MRNA

Market Cap: $57.13B

MI

Moderna, Inc.

MRNA

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Moderna (MRNA) Financials & Key Data

Financials

Profitability

Gross Profit Margin-12.57%

EBITDA Margin-1.27%

EBIT Margin-1.38%

Pre-tax Margin-1.39%

Net Profit Margin-1.41%

Earnings Yield-5.53%

Valuation Multiples

Price / Book8.43

Price / Sales25.64

Price / Earnings-18.04

PEG2.14

Forward PEG0.43

EV / Sales25.44

Cash Flow & Capital

Free Cash Flow / Share-$3.09

Operating Cash Flow / Share-$2.66

Free Cash Flow Yield-2.14%

Capex / Revenue7.68%

Capex / Operating Cash Flow-16.25%

Capex / Depreciation0.98

Liquidity & Leverage

Current Ratio2.29

Quick Ratio2.18

Cash Ratio0.68

Debt / Assets0.12

Debt / Capital0.16

Debt / Equity0.19

Efficiency & Working Capital

Asset Turnover0.20

Fixed Asset Turnover0.81

Inventory Turnover8.96

Receivables Turnover21.63

Payables Turnover15.02

Days Sales Outstanding16.87

Returns & Quality

Return on Equity-39.20%

Return on Assets-28.75%

Return on Invested Capital-39.16%

ROCE-39.40%

Return on Tangible Assets-29.18%

Operating Return on Assets-29.58%

Balance Sheet & Intrinsic Metrics

Enterprise Value$56.69B

Invested Capital$6.2B

Working Capital$3.28B

Tangible Asset Value$6.6B

Net Current Asset Value$1.62B

Graham Net-Net

Financial Health Scores

Piotroski Score2

Altman Z-Score8.03

Revenue$2.23B

EBIT$-3.07B

Market Cap$54.21B

Working Capital$3.28B

EV / EBITDA

-20.04

EV / Operating Cash Flow-53.89

EV / Free Cash Flow-46.35

Price / Free Cash Flow-46.71

Price / Operating Cash Flow-54.19

Stock Compensation / Revenue15.66%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Long-Term Debt / Capital

0.08

Debt / Market Cap1.13%

Net Debt / EBITDA0.15

Solvency Ratio-0.69

Financial Leverage1.62

Days Inventory Outstanding40.75

Days Payables Outstanding24.3

Operating Cycle57.62

Cash Conversion Cycle33.32

Working Capital Turnover0.67

Income Quality0.33

Tax Burden1.02

Interest Burden1.01

$2.92

Book Value / Share$17.07

Tangible Book Value / Share$16.67

Cash / Share$12.97

Retained Earnings

$5.1B

Total Assets$10.96B

Total Liabilities$4.2B